Health

FDA Approves Alhemo as Once-Daily Prophylactic Treatment to Prevent or Reduce the Frequency of Bleeding Episodes for Adults and Children 12 Years of Age and Older with Hemophilia A or B (HA/HB) Without Inhibitors

DailyTrendDailyTrend
Aug 3, 2025 - 19:00
 0  0
FDA Approves Alhemo as Once-Daily Prophylactic Treatment to Prevent or Reduce the Frequency of Bleeding Episodes for Adults and Children 12 Years of Age and Older with Hemophilia A or B (HA/HB) Without Inhibitors
PLAINSBORO, N.J., July 31, 2025 /PRNewswire/ -- Novo Nordisk announced today that the US Food and Drug Administration (FDA) approved Alhemo (concizumab-mtci) injection as a once-daily prophylaxis to prevent or reduce the frequency of bleeding...
Read More

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0
DailyTrend
DailyTrend

Related Posts

FDA Approves Apellis’ Empaveli (pegcetacoplan) as the First C3G and Primary IC-MPGN Treatment for Patients 12 and Older

FDA Approves Apellis’ Empaveli (pegcetacoplan) as the F...

DailyTrend Jul 30, 2025  0  0

For Some, Return of Presidential Fitness Test Revives Painful Memories

For Some, Return of Presidential Fitness Test Revives P...

DailyTrend Aug 2, 2025  0  0

Major Study on Transgender Youth Health Care to Begin in U.K.

Major Study on Transgender Youth Health Care to Begin i...

DailyTrend Jul 31, 2025  0  0

US FDA Approves New Biktarvy Indication For People With HIV Who Are Treatment Experienced And Restarting Antiretroviral Treatment

US FDA Approves New Biktarvy Indication For People With...

DailyTrend Aug 2, 2025  0  0

Sobi Announces U.S. Food and Drug Administration Approves Doptelet (avatrombopag) for the Treatment of Thrombocytopenia in Pediatric Patients One Year and Older with Persistent or Chronic Immune Thrombocytopenia (ITP)

Sobi Announces U.S. Food and Drug Administration Approv...

DailyTrend Jul 29, 2025  0  0

Morton Mintz, Muckraking Crusader for Consumers, Dies a...

DailyTrend Jul 30, 2025  0  0